Furthermore, the failure to achieve complete hematological response or resistance to sequential tyrosine kinase inhibitors, or occurrence of > 2 mutations on BCR::ABL during treatment, has also been eliminated in the definition of AP. This evidence concerns the gene ABL1 and alkaline phosphatase measurement.